When diet fails: Insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 11, Issue 4, 2002, Pages 218-225

  Langer, O ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Gestational diabetes mellitus; Insulin; Oral hypoglycemic agents

Indexed keywords

ACARBOSE; BIGUANIDE DERIVATIVE; CHLORPROPAMIDE; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; INSULIN; METFORMIN; MIGLITOL; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SULFONYLUREA DERIVATIVE; ALPHA GLUCOSIDASE; ANTIDIABETIC AGENT; ENZYME INHIBITOR; THIAZOLE DERIVATIVE;

CLINICAL RESEARCH; DIET THERAPY; DRUG MECHANISM; DRUG SAFETY; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; HUMAN; NEWBORN MORBIDITY; OUTCOMES RESEARCH; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; CLINICAL TRIAL; DRUG ANTAGONISM; FEMALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PREGNANCY; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ALPHA-GLUCOSIDASES; BIGUANIDES; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; ENZYME INHIBITORS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PRACTICE GUIDELINES; PREGNANCY; SULFONYLUREA COMPOUNDS; THIAZOLES; TREATMENT FAILURE;

EID: 0036022656     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/jmf.11.4.218.225     Document Type: Review

References (69)

1. Gestational diabetes
2. Management of gestational diabetes
3. Maternal glycemic criteria for insulin therapy in gestational diabetes mellitus
4. A placebo-controlled randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful
5. A comparison of glyburide and insulin in women with gestational diabetes mellitus
6. The role of insulin resistance in human disease
7. Pathogenesis of non-insulin dependent diabetes (type 2)
8. Clinical aspects of islet B cell function in non-insulin dependent diabetes mellitus
9. Metabolic signaling of insulin secretion
10. Intensfied vs. conventional management of gestational diabetes
11. Management of diabetes mellitus and pregnancy: A survey of obstetricians and maternal-fetal specialists
12. The potential diabetic and her treatment in pregnancy
13. Insulin therapy for gestational diabetes
14. Prophylactic insulin in the management of gestational diabetes
15. Gestational diabetes mellitus (GDM). Comparative evaluation of two treatment regimens, diet versus insulin and diet
16. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy
17. Rationale for insulin management in gestational diabetes mellitus
18. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes
19. Dietary therapy for gestational diabetes: How long is long enough?
20. Management of gestational diabetes
21. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: A pilot study
22. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
23. Implications of the United Kingdom Prospective Diabetes Study
24. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies
25. Insulin secretagogues: Old and new
26. Use of chlorpropamide in the treatment of diabetes in pregnancy
27. Tolbutamide and chloroprompamide during pregnancy in human diabetics
28. Effect of moderate dosage of chloropropamide in pregnancy on fetal outcome
29. The use of sulphonylureas bigunides and insulin in pregnancy
30. Oral hypoglycemics in the first trimester and fetal outcome
31. Pregnancy in established noninsulin-dependent diabetics
32. Oral hypoglycemic therapy in diabetic pregnancies
33. Sulfonylurea drugs in pregnancy
34. Sulfonylurea therapy in the treatment of the pregnant diabetic
35. The management of non-insulin-dependent diabetes during pregnancy
36. Oral hypoglycemic agents in the treatment of gestational diabetes
37. Metformin in management of pregnant insulin-independent diabetics
38. Sulphonylureas in pregnancy
39. Oral hypoglycemic agents
40. Neonatal hypoglycemia in infants of diabetic mothers given sulphonylurea drugs in pregnancy
41. Hypoglycemia in newborn infants of normal and diabetic mothers
42. Prolonged symptomatic neonatal hypoglycemia associated with maternal chlorpropamide therapy
43. Teratogenic effects of chlorpropamide in mouse embryos in vitro
44. Embryopathic effects of short-term exposure to hypoglycemia in the mouse
45. Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis
46. Gestational diabetes mellitus. American Diabetes Association: Clinical practice recommendations
47. Summary and recommendations of the fourth international workshop conference on gestational diabetes
48. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects
49. Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans
50. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals
51. Glucose toxicity
52. Mechanism of improvement in glucose metabolism after chronic glyburide therapy
53. Insignificant transfer of glyburide occurs across the human placenta
54. Comparative placental transport of oral hypoglycemic agents. A model of human placental drug transfer
55. A model of human placental drug transfer
56. Glyburide vs. insulin in women with gestational diabetes mellitus
57. Diabetes Review. Pharmacological therapy of diabetes
58. Chlorpropamide and perinatal mortality
59. Metformin hydrochloride: An antihyperglycemic agent
60. Peroxisome proliferator-activitated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats
61. Thiazolidinediones
62. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM
63. α-Glucosidase inhibitors
64. Glyburide vs. insulin in women with gestational diabetes mellitus